CABA Stock Analysis: Buy, Sell, or Hold?
CABA - Cabaletta Bio, Inc. Common Stock
$2.57
-0.18 (-6.55%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 12, 2026
Get Alerted When CABA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
5 traders called CABA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CABA is down 19.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CABA is down 19.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CABA is currently trading at $2.57, which is considered slightly high relative to its 30-day fair value range of $2.04 to $2.70.
Technical Outlook: Technically, CABA is in a downtrend. Immediate support is located at $2.04, while resistance sits at $3.34. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: CABA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.12 (+377.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CABA is in a downtrend. Immediate support is located at $2.04, while resistance sits at $3.34. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: CABA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.12 (+377.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$2.04 -
$2.70
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
Protect Your Profits
Holding CABA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.5%)
- BULLISH: Trading 377.3% below Wall St target ($13.12)
- WARNING: Recommendation downgraded due to -19.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.04 -
$2.70
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.04
Resistance Level
$3.34
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.64
Wall Street Target
$13.13
(+377.3%)
Last updated: January 30, 2026 5:38 PM ET
Data refreshes hourly during market hours. Next update: 6:38 PM
Data refreshes hourly during market hours. Next update: 6:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CABA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced CABA Option Strategies
Professional options setups generated by AI based on today's CABA price and gamma walls.
